GVHD-budesonide trial
Phase 2
Recruiting
- Conditions
- Intestinal acute GVHD
- Registration Number
- JPRN-jRCTs021210039
- Lead Sponsor
- Yamashita Takaya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
(1) Intestinal acute GVHD
(2) Untreated
(3) Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0 to 2
(4) Written informed consent
Exclusion Criteria
(1) Post-treatment for GVHD
(2) Skin GVHD stage 3 or higher, liver GVHD stage 1 or higher.
(3) Active infection
(4) Intestinal disease due to other causes (e.g. CMV enteritis, thrombotic microangiopathy)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method